Know Cancer

or
forgot password

INI-1 Deletions in Ewing Sarcoma


N/A
N/A
N/A
Open (Enrolling)
Both
Sarcoma

Thank you

Trial Information

INI-1 Deletions in Ewing Sarcoma


OBJECTIVES:

- To determine the frequency of INI-1 protein loss in Ewing Sarcoma.

OUTLINE: Previously collected tissue samples are analyzed for INI-1 protein loss by IHC and
tissue microarray.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of Ewing sarcoma

- Prepared tissue microarray with Ewing sarcoma samples available

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

Frequency of INI1 protein loss in Ewing Sarcoma

Safety Issue:

No

Principal Investigator

Joshua D. Schiffman, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Utah

Authority:

United States: Federal Government

Study ID:

CDR0000701010

NCT ID:

NCT01365949

Start Date:

May 2011

Completion Date:

Related Keywords:

  • Sarcoma
  • Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)
  • Sarcoma, Ewing's
  • Neuroectodermal Tumors, Primitive, Peripheral
  • Sarcoma

Name

Location